Back to Search Start Over

Prognostic significance of remotely monitored nocturnal heart rate in heart failure patients with reduced ejection fraction.

Authors :
D'Onofrio A
Marini M
Rovaris G
Zanotto G
Calvi V
Iacopino S
Biffi M
Solimene F
Della Bella P
Caravati F
Pisanò EC
Amellone C
D'Alterio G
Pedretti S
Santobuono VE
Russo AD
Nicolis D
De Salvia A
Baroni M
Quartieri F
Manzo M
Rapacciuolo A
Saporito D
Maines M
Marras E
Bontempi L
Morani G
Giacopelli D
Gargaro A
Giammaria M
Source :
Heart rhythm [Heart Rhythm] 2023 Feb; Vol. 20 (2), pp. 233-240. Date of Electronic Publication: 2022 Oct 28.
Publication Year :
2023

Abstract

Background: Elevated resting heart rate is a risk factor for cardiovascular events.<br />Objective: The purpose of this study was to investigate the clinical significance of nocturnal heart rate (nHR) and 24-hour mean heart rate (24h-HR) obtained by continuous remote monitoring (RM) of implantable devices.<br />Methods: We analyzed daily-sampled trends of nHR, 24h-HR, and physical activity in patients on β-blocker therapy for chronic heart failure and with implantable cardioverter-defibrillators or cardiac resynchronization therapy defibrillators (CRT-Ds). Patients were grouped by average nHR and 24h-HR quartile during follow-up to estimate the respective incidence of nonarrhythmic death and device-treated ventricular tachycardia/fibrillation (VT/VF).<br />Results: The study cohort included 1330 patients (median age 69 years [interquartile range 61-77 years]; 41% [n = 550] with CRT-D; median follow-up 25 months [interquartile range 13-42 months]). Compared with patients in the lowest nHR quartile (≤57 beats/min) group, patients in the highest quartile group (>65 beats/min) had an increased risk of nonarrhythmic death (adjusted hazard ratio [AHR] 2.25; 95% confidence interval [CI] 1.13-4.50; P = .021) and VT/VF (AHR 1.98; 95% CI 1.40-2.79; P < .001) and were characterized by the lowest level of physical activity (P ≤ .0004 vs every other nHR quartiles). The highest 24h-HR quartile group (>75 beats/min) showed an increased risk of VT/VF (AHR 2.13; 95% CI 1.52-2.99; P < .001) and a weaker though significant association with nonarrhythmic mortality (AHR 1.80; 95% CI 1.00-3.22; P = .05) as compared with the lowest 24h-HR quartile group (≤65 beats/min).<br />Conclusion: In remotely monitored patients with implantable cardioverter-defibrillator/CRT-D on β-blocker therapy for heart failure, elevated heart rates (nHR >65 beats/min and 24h-HR >75 beats/min) were associated with increased mortality and VT/VF risk. nHR showed a stronger association than 24h-HR with worst prognosis and lowest physical activity.<br /> (Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1556-3871
Volume :
20
Issue :
2
Database :
MEDLINE
Journal :
Heart rhythm
Publication Type :
Academic Journal
Accession number :
37283031
Full Text :
https://doi.org/10.1016/j.hrthm.2022.10.018